Deccan Health Care MD, chairman, board of directors and AGM
BSE: 542248Healthcare ServicesSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹12.73.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹29 Cr3,846th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 14 Aug 2026
- 11.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 0.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- 2.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 3.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.04
- Volume, BSEVolume. Shares traded on the last trading day.
- 2,050
Deccan Health Care board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Chairperson and managing directorMinto Purshotam Gupta
- Company Secretary and Compliance OfficerShikha Das
10 directors5 independent2 executive3 non-executive
- Minto Purshotam Gupta · Chairperson and managing directorExecutive · joined Feb 2000 · reappointed Sep 2022 · 1 listed board
- Meenakshi GuptaNon-executive · joined Oct 2014 · reappointed Sep 2022 · 1 listed board · 2 committee seats
- Mohak GuptaExecutive · joined Apr 2025 · reappointed Apr 2025 · 1 listed board · 1 committee seat
- Ravi RamprasadNon-executive · joined Sep 2022 · reappointed Sep 2022 · 1 listed board
- Umanja Venkata Satya Siva SriharikollaNon-executive · joined Feb 2024 · reappointed Feb 2024 · 1 listed board
- Viraj Shaileshkumar ShahIndependent · joined Mar 2023 · reappointed Mar 2023 · 60 months as independent · 2 listed boards · 2 as independent
- Ruchi KhattarIndependent · joined Sep 2020 · reappointed Sep 2025 · 60 months as independent · 1 listed board · 1 as independent · 2 committee seats, 2 as chair
- Bhupender Singh katariaIndependent · joined Apr 2026 · reappointed Apr 2026 · 60 months as independent · 1 listed board · 1 as independent · 1 committee seat
- Pratiksha BishtIndependent · joined Apr 2026 · reappointed Apr 2026 · 60 months as independent · 1 listed board · 1 as independent · 1 committee seat
- Manju SinghIndependent · joined Apr 2026 · reappointed Apr 2026 · 60 months as independent · 1 listed board · 1 as independent
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
4 directors who left
- Bhavika Sanghani, left 29 Jun 2026: Others
- Karishma Patel, left 10 Mar 2026: Others
- Samhitha Kandlakunta, left 9 Mar 2026: Others
- Ramesh Kumar, left 31 Dec 2024: Others
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 30 May 20267 of 11 present4 independent · 34 days in between
- 25 Apr 20265 of 11 present1 independent · 70 days in between
- 13 Feb 20268 of 10 present3 independent
Audit Committee
Chair Ruchi Khattar
Meenakshi Gupta, Bhupender Singh kataria
- 30 May 20263 of 3 present2 independent · 105 days in between
- 13 Feb 20262 of 3 present2 independent
Nomination and remuneration committee
Chair Ruchi Khattar
Meenakshi Gupta, Pratiksha Bisht
- 25 Apr 20262 of 3 present1 independent
Stakeholders Relationship Committee
Chair Ruchi Khattar
Meenakshi Gupta, Mohak Gupta
No meeting listed in the filing.
Corporate Social Responsibility Committee
Chair Ruchi Khattar
Meenakshi Gupta, Manju Singh
No meeting listed in the filing.
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Jun 2026.
- Keyur Shah & AssociatesPeer-review certificate valid to Jul 2027
1 earlier auditor
- Keyur Shah and AssociatesNamed in the filing for the quarter to Mar 2025
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Deccan Health Care AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Deccan Health Care share news and announcements
Annual general meeting, 30 Sep 2026
4,263 shareholders on the register on 25 Sep 2026; present: 3 promoters and 23 others; votes counted by Monika Bhatia / M/s M.R Bhatia & Co. Company Secretaries.The company's voting result (opens in a new tab)
To receive, consider and adopt: a. the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026, together with the Reports of the Board of Directors and the Auditors thereon; and, b. the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, together with the Report of the Auditors thereon.MoreLess
Ordinary99.59% for0.41% againstAgainst: promoters 0.00% · institutions 0.00% · other public 1.06%
Turnout: all 30.93% · promoters 100.00% · institutions 0.00% · other public 15.98%
- To appoint a director in place of Mr. Umanja Venkata Satya Siva Srihari Kolla (DIN: 01638116), who retires by rotation and being eligible, offers himself for re-appointment.Ordinary99.59% for0.41% against
Against: promoters 0.00% · institutions 0.00% · other public 1.06%
Turnout: all 30.93% · promoters 100.00% · institutions 0.00% · other public 15.98%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Fines
Reported in the filing for the quarter to Jun 2026.
- Fine or penaltyBSESince 23 Apr 2026
Rs. 20,000 per day of non-compliance till the date of compliance.
company has not approached the exchange for trading approval within 7 working days from the date of grant of Listing approval (13/10/2025)
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- Yes
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Jun 2025. The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it. A preferential issue sells new shares to chosen investors rather than to the public. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Preferential IssuesApr 2025 | 1.61 | The proceeds of the preferential offer are proposed to be used to augment our capital base, to meet increased working capital requirements and the General Corporate purposes or such other objects, as the Board may from time to time decide in the best interest of the Company | 1.61 | 1.61 | No |
| Preferential IssuesApr 2025 | 1.37 | The proceeds of the preferential offer are proposed to be used to augment our capital base, to meet increased working capital requirements and the General Corporate purposes or such other objects, as the Board may from time to time decide in the best interest of the Company | 1.37 | 1.37 | No |